Mercury Laboratories Ltd

Mercury Laboratories Management Change

Mercury Laboratories has appointed Mr. Jaydeepsinh Raj as Manager-HR, effective September 03, 2026.

Mercury Laboratories Annual Report

Mercury Laboratories Ltd has submitted its 45th Annual Report and Notice of the 45th AGM for the financial year 2025-26.

Mercury Laboratories Annual General Meeting

Mercury Laboratories has issued the notice for its 45th Annual General Meeting, scheduled for September 28, 2026. The meeting will address dividend declaration and director re-appointments.

Mercury Laboratories Management Change

Mercury Laboratories appointed Sunil Sharma as Head of Injectable Production effective August 21, 2026. Simultaneously, Ms. Seema Salvi resigned from the same position to pursue other opportunities.

Mercury Laboratories Other Announcement

Mercury Laboratories informs shareholders regarding Tax Deduction at Source (TDS) requirements for the FY 2025-26 dividend. This communication outlines necessary compliance and record-updating procedures.

Mercury Laboratories Q1 FY27 Results: Net Profit ₹0.3 Cr, Down 70.0% YoY

Mercury Laboratories Ltd reported revenue from operations of ₹16 Cr (-11.6% YoY) and net profit of ₹0.3 Cr (-70.0% YoY) for Q1 FY27.

Key figure

Net profit ₹0.3 Cr · -70.0% YoY

Mercury Laboratories Board Meeting Date

Mercury Laboratories scheduled a board meeting for July 25, 2026. The board will consider and approve unaudited financial results for the June quarter.